These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2826995)

  • 1. Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor.
    Erhardt PW; Hagedorn AA; Sabio M
    Mol Pharmacol; 1988 Jan; 33(1):1-13. PubMed ID: 2826995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
    Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue and species specificity of cardiac cAMP-phosphodiesterase inhibitors.
    Pang DC
    Adv Second Messenger Phosphoprotein Res; 1992; 25():307-20. PubMed ID: 1313264
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic AMP phosphodiesterase inhibition by coumarins and furanocoumarins.
    Sardari S; Nishibe S; Horita K; Nikaido T; Daneshtalab M
    Pharmazie; 1999 Jul; 54(7):554-6. PubMed ID: 10445247
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of indolidan analog binding sites of drug antibody and sarcoplasmic reticulum with inhibition of cyclic AMP phosphodiesterase.
    Ashikaga T; Robertson DW; Sportsman RJ; Strada SJ; Thompson WJ
    J Recept Signal Transduct Res; 1996; 16(5-6):315-37. PubMed ID: 8968964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR study of phosphodiesterase inhibitory activity of imidazo[2,1-b]-quinazolines: active site analysis.
    Prabhakar YS
    Drug Des Deliv; 1989 Dec; 5(2):81-91. PubMed ID: 2577989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the identification of the cardiac cGMP inhibited-phosphodiesterase catalytic site.
    Fossa P; Boggia R; Mosti L
    J Comput Aided Mol Des; 1998 Jul; 12(4):361-72. PubMed ID: 9777494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4.
    Kleinman EF; Campbell E; Giordano LA; Cohan VL; Jenkinson TH; Cheng JB; Shirley JT; Pettipher ER; Salter ED; Hibbs TA; DiCapua FM; Bordner J
    J Med Chem; 1998 Jan; 41(3):266-70. PubMed ID: 9464356
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs.
    Harrison SA; Chang ML; Beavo JA
    Circulation; 1986 Mar; 73(3 Pt 2):III109-16. PubMed ID: 3002661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Imidazolylphenyl)pyrrol-2-one inhibitors of cardiac cAMP phosphodiesterase.
    Lampe JW; Chou YL; Hanna RG; Di Meo SV; Erhardt PW; Hagedorn AA; Ingebretsen WR; Cantor E
    J Med Chem; 1993 Apr; 36(8):1041-7. PubMed ID: 8386770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines].
    Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA
    Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for potent and selective inhibition of low-Km, cyclic-AMP-specific phosphodiesterases.
    Robertson DW; Boyd DB
    Adv Second Messenger Phosphoprotein Res; 1992; 25():321-40. PubMed ID: 1313265
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of cardiac phosphodiesterase III by the novel cardiotonic agent 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride.
    Sellin LC; Alajoutsijärvi A; Törnquist K; Fraser M; Pippuri A; Ojala I
    Arzneimittelforschung; 1988 Dec; 38(12):1787-9. PubMed ID: 2854467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotonic agents. 5. Fragments from the heterocycle-phenyl-imidazole pharmacophore.
    Erhardt PW; Hagedorn AA; Davey D; Pease CA; Venepalli BR; Griffin CW; Gomez RP; Wiggins JR; Ingebretsen WR; Pang D
    J Med Chem; 1989 Jun; 32(6):1173-6. PubMed ID: 2542552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP phosphodiesterase from human heart and drug action.
    Tanaka T; Masuoka H; Ito M; Nakano T; Naka M; Hidaka H
    Adv Second Messenger Phosphoprotein Res; 1992; 25():373-81. PubMed ID: 1313268
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of purine inhibitors of phosphodiesterase 7 (PDE7).
    Pitts WJ; Vaccaro W; Huynh T; Leftheris K; Roberge JY; Barbosa J; Guo J; Brown B; Watson A; Donaldson K; Starling GC; Kiener PA; Poss MA; Dodd JH; Barrish JC
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2955-8. PubMed ID: 15125967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
    Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
    Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.